The nano enterprise: A survey of health and safety concerns, considerations, and proposed improvement strategies to reduce potential adverse effects

Nanotechnology is evolving to become a leading industry. However, there is a great deal of uncertainty surrounding the potential health effects of nanomaterials and its components. This study focuses on the hazards and risks that nanomaterials pose to physical and environmental health together with the risks posed during their manufacture and research. In particular, the authors seek to promote awareness and the need for the adoption of various strategies to minimize the risk of human exposure to nanotechnologies both within and outside the manufacturing enterprise. Information from scientific journals, project studies, environmental and worker-protection agency reports are used as the main source for this study. The six sigma's DMAIC framework, viz. “define, measure, analyze, improve, and control,” is used as a guideline for synthesizing information from published literature. Preliminary evidence from experimental research studies indicate the ability of nanomaterials to penetrate and cause damage to human tissues and cells. The susceptibility of the personnel associated during production (those who are more likely to be at risk) has been analyzed to examine considerations and targets, as well as for developing strategies for a continued research framework. Nanotechnology may pose health and environmental hazards unless adequate preventive measures are developed and implemented. Because of the likely unfavorable health effects on individuals conducting experiments and handling nanomaterials, studies that identify the adverse effects of nanotechnology must be conducted at a pace level with the commercialization of nanotechnology. © 2006 Wiley Periodicals, Inc. Hum Factors Man 16: 343–368, 2006.

[1]  K. Donaldson,et al.  Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types , 2004, Occupational and Environmental Medicine.

[2]  E. K. Gannett,et al.  THE INSTITUTE OF ELECTRICAL AND ELECTRONICS ENGINEERS , 1965 .

[3]  R. Auerbach,et al.  An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[4]  L. Szentkuti,et al.  Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon , 1997 .

[5]  Benoit Nemery,et al.  Ultrafine particles affect experimental thrombosis in an in vivo hamster model. , 2002, American journal of respiratory and critical care medicine.

[6]  Benoit Nemery,et al.  Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. , 2003, Toxicology and applied pharmacology.

[7]  Dana Loomis,et al.  Work in Brief , 2006 .

[8]  J. Carter,et al.  Effects of particle exposure and particle-elicited inflammatory cells on mutation in rat alveolar epithelial cells. , 1997, Carcinogenesis.

[9]  V. Colvin The potential environmental impact of engineered nanomaterials , 2003, Nature Biotechnology.

[10]  Fiona N Moore Implications of nanotechnology applications: using genetics as a lesson. , 2002, Health law review.

[11]  Robert Gelein,et al.  EXTRAPULMONARY TRANSLOCATION OF ULTRAFINE CARBON PARTICLES FOLLOWING WHOLE-BODY INHALATION EXPOSURE OF RATS , 2002, Journal of toxicology and environmental health. Part A.

[12]  Waldemar Karwowski,et al.  The emerging field of health engineering , 2006 .

[13]  Gerhard Mueller,et al.  Penetration of Titanium Dioxide Microparticles in a Sunscreen Formulation into the Horny Layer and the Follicular Orifice , 1999, Skin Pharmacology and Physiology.

[14]  A. Arnall,et al.  Moving the nanoscience and technology (NST) debate forwards: short-term impacts, long-term uncertainty and the social constitution , 2005 .

[15]  Mark D. Hoover,et al.  Dose-response relationships between inhaled beryllium metal and lung toxicity in C3H mice. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  Mads Kreilgaard,et al.  Influence of microemulsions on cutaneous drug delivery. , 2002, Advanced drug delivery reviews.

[17]  Vincent W. Bramwell,et al.  Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. , 2001, Vaccine.

[18]  T. Webb,et al.  Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  Ken Geiser Nanotechnology and Environmental and Public Health Considerations , 2004, New solutions : a journal of environmental and occupational health policy : NS.

[20]  P. Baron,et al.  Exposure to Carbon Nanotube Material: Aerosol Release During the Handling of Unrefined Single-Walled Carbon Nanotube Material , 2004, Journal of toxicology and environmental health. Part A.

[21]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  Jenny R. Roberts,et al.  Skin as a route of exposure and sensitization in chronic beryllium disease. , 2003, Environmental health perspectives.

[23]  P. Dubruel,et al.  Poly-L-glutamic acid derivatives as vectors for gene therapy. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[24]  W. Kreyling,et al.  Translocation of Inhaled Ultrafine Particles to the Brain , 2004, Inhalation toxicology.

[25]  P. Baron,et al.  Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity using Human Keratinocyte Cells , 2003, Journal of toxicology and environmental health. Part A.

[26]  E Fattal,et al.  Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. , 1997, Biomaterials.